Racura Oncology Overview
- Year Founded
-
2011
- Status
-
Public
- Employees
-
4
- Stock Symbol
-
RAC
- Investments
-
2
- Share Price
-
$1.07
- (As of Friday Closing)
Racura Oncology General Information
Description
Racura Oncology Ltd is a Phase 3 clinical-stage biopharmaceutical company with a dedicated mission to silence cancer. The company's clinical programs include the Phase 3 EMILI trial in acute myeloid leukaemia, the Phase 1a/b HARNESS trial in combination with osimertinib for EGFR-mutated non-small cell lung cancer, and the Phase 1a/b CPACS trial in combination with doxorubicin, where it aims to deliver both anthracycline cardioprotection and enhanced anticancer activity. The company operated in two segments, being research into an oncology drug, RC220, and the manufacturing and distribution of the drug for clinical trials.
Contact Information
Website
www.racuraoncology.comCorporate Office
- Level 36, Gateway Tower
- 1 Macquarie Place
- Sydney, New South Wales 2000
- Australia
Corporate Office
- Level 36, Gateway Tower
- 1 Macquarie Place
- Sydney, New South Wales 2000
- Australia
Racura Oncology Timeline
Racura Oncology Stock Performance
As of 20-Nov-2026, Racura Oncology’s stock price is $1.07. Its current market cap is $211M with 196M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.07 | $1.06 | $0.98 - $2.58 | $211M | 196M | 88.9K |
Racura Oncology Financials Summary
As of 30-Sep-2026, Racura Oncology has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 235,010 | 285,138 | 121,080 | 197,557 |
| EBITDA | (7,736) | (3,426) | (9,418) | |
| Net Income | (7,512) | (3,097) | (9,056) | |
| Total Assets | 26,213 | 11,424 | 13,521 | |
| Total Debt | 0 | 0 | 0 |
Racura Oncology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Racura Oncology Patents
Racura Oncology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024903211-A0 | Pharmaceutical compositions suitable for intravenous administration | Pending | 04-Oct-2024 | ||
| WO-2026073303-A1 | Pharmaceutical compositions suitable for intravenous administration | Pending | 04-Oct-2024 | ||
| AU-2022901827-A0 | Method of cardioprotection | Inactive | 30-Jun-2022 | ||
| AU-2022901791-A0 | Treatment of melanoma | Inactive | 27-Jun-2022 | ||
| AU-2022901702-A0 | Treatment of melanoma | Inactive | 22-Jun-2022 |
Racura Oncology Signals
Racura Oncology Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Racura Oncology Investments & Acquisitions (2)
Racura Oncology’s most recent deal was a Joint Venture with Race Immunotherapeutics. The deal was made on 10-Jul-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Race Immunotherapeutics | 10-Jul-2017 | Joint Venture | Drug Discovery | ||
| Update Pharma | 01-Jul-2016 | Merger/Acquisition | Drug Discovery |
Racura Oncology ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Racura Oncology FAQs
-
When was Racura Oncology founded?
Racura Oncology was founded in 2011.
-
Where is Racura Oncology headquartered?
Racura Oncology is headquartered in Sydney, Australia.
-
What is the size of Racura Oncology?
Racura Oncology has 4 total employees.
-
What industry is Racura Oncology in?
Racura Oncology’s primary industry is Biotechnology.
-
Is Racura Oncology a private or public company?
Racura Oncology is a Public company.
-
What is Racura Oncology’s stock symbol?
The ticker symbol for Racura Oncology is RAC.
-
What is the current stock price of Racura Oncology?
As of 20-Nov-2026 the stock price of Racura Oncology is $1.07.
-
What is the current market cap of Racura Oncology?
The current market capitalization of Racura Oncology is $211M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process